RARE vs RGR · rev $350.0M vs P/E 20, rev $299.4M
Ultragenyx (RARE) versus Sturm Ruger & Company Inc (RGR) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Sturm Ruger & Company Inc (RGR) is a aerospace & defense company listed on US.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported RGR revenue for 2026-06-27 was $299.4M. Net income was $7.1M. RGR currently screens at market cap $604.6M and trailing P/E 20.0.
RARE currently screens at market cap $2.79B. RGR currently screens at market cap $604.6M and trailing P/E 20.0.
Not investment advice. Open the RARE and RGR stock pages for the full models.
Not investment advice.